The 131st Annual Meeting (November 15-19, 2003) of APHA |
Florence J. Dallo, MPH and Susan C. Weller, PhD. Preventive Medicine and Community Health, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1153, 409-772-2551, fjdallo@utmb.edu
ABSTRACT
Objectives. Although screening guidelines exist to
detect new cases of diabetes mellitus (DM), about one-third of cases are
undiagnosed and complications may be present two to ten years prior to
diagnosis. This raises the question of
whether the guidelines are adequate to detect new cases of DM. This study evaluates the effectiveness of
the 2002 Expert Committee on the Diagnosis and Classification of Diabetes
Mellitus testing in asymptomatic, undiagnosed individuals.
Methods. The Third National Health and Nutrition
Examination Survey, NHANES III, (1988-1994) is a multi-stage probability sample
of US adults with clinical and survey data.
Adults ³20 without a prior diagnosis of diabetes who had a
morning fasting plasma glucose (FPG) were classified as non-diabetics
(FPG<126, n=6,240) and diabetics (FPG³126, n=274). The guideline risk factors were compared
between the two groups.
Results. Screening for one or more risk factors has
94.4% sensitivity and requires that 79.2% of the population be tested. Screening when two or more risk factors are
present has comparable sensitivity (92.8%) and requires that 56.2% of the
population be tested. Since DM occurs
at younger ages for minorities, screening whites who are ³40 or
minorities who are ³30 has 95.0% sensitivity and requires that 59.8%
of the population be tested.
Conclusions. Following screening recommendations would essentially eliminate undiagnosed cases of DM. Screening for two risk factors or using a simple age-based decision-rule would obtain similar sensitivity, and would reduce the necessary testing by approximately 20%. Efficacious guidelines exist, but implementation of the guidelines remains the greatest challenge.
Learning Objectives:
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.